These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 17714704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ferrara N, Damico L, Shams N, Lowman H, Kim R.
    Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284
    [Abstract] [Full Text] [Related]

  • 3. VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells.
    Deissler H, Deissler H, Lang S, Lang GE.
    Br J Ophthalmol; 2008 Jun; 92(6):839-43. PubMed ID: 18511543
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of neovascular age-related macular degeneration with Ranibizumab/Lucentis].
    Michels S, Rosenfeld PJ.
    Klin Monbl Augenheilkd; 2005 Jun; 222(6):480-4. PubMed ID: 15973626
    [Abstract] [Full Text] [Related]

  • 6. Ranibizumab for the treatment of neovascular AMD.
    Kaiser PK, Do DV.
    Int J Clin Pract; 2007 Mar; 61(3):501-9. PubMed ID: 17313620
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits.
    Gaudreault J, Fei D, Beyer JC, Ryan A, Rangell L, Shiu V, Damico LA.
    Retina; 2007 Mar; 27(9):1260-6. PubMed ID: 18046235
    [Abstract] [Full Text] [Related]

  • 8. VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.
    Ueda Y, Yamagishi T, Ikeya H, Hirayama N, Itokawa T, Aozuka Y, Samata K, Nakaike S, Tanaka M, Ono M, Saiki I.
    Anticancer Res; 2004 Mar; 24(5A):3009-17. PubMed ID: 15517909
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells.
    Deissler HL, Deissler H, Lang GE.
    Br J Ophthalmol; 2011 Aug; 95(8):1151-6. PubMed ID: 21273213
    [Abstract] [Full Text] [Related]

  • 10. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
    Héroult M, Bernard-Pierrot I, Delbé J, Hamma-Kourbali Y, Katsoris P, Barritault D, Papadimitriou E, Plouet J, Courty J.
    Oncogene; 2004 Mar 04; 23(9):1745-53. PubMed ID: 15001987
    [Abstract] [Full Text] [Related]

  • 11. Comparison of binding characteristics and in vitro activities of three inhibitors of vascular endothelial growth factor A.
    Yang J, Wang X, Fuh G, Yu L, Wakshull E, Khosraviani M, Day ES, Demeule B, Liu J, Shire SJ, Ferrara N, Yadav S.
    Mol Pharm; 2014 Oct 06; 11(10):3421-30. PubMed ID: 25162961
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Ranibizumab for treatment of exudative age-related macular degeneration--own experience].
    Wykrota H, Gierek-Lapińska A, Trzciakowski K, Gajdzik-Gajdecka U.
    Klin Oczna; 2007 Oct 06; 109(10-12):402-9. PubMed ID: 18488382
    [Abstract] [Full Text] [Related]

  • 14. [The results of wet AMD treatment by intravitreal injections--preliminary report].
    Okruszko A, Borucka AI, Ulińska M, Szaflik J.
    Klin Oczna; 2007 Oct 06; 109(10-12):389-93. PubMed ID: 18488380
    [Abstract] [Full Text] [Related]

  • 15. Bevacizumab and ranibizumab on microvascular endothelial cells: A comparative study.
    Costa R, Carneiro A, Rocha A, Pirraco A, Falcão M, Vasques L, Soares R.
    J Cell Biochem; 2009 Dec 15; 108(6):1410-7. PubMed ID: 19859900
    [Abstract] [Full Text] [Related]

  • 16. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW, Kim SJ, Choi HJ, Kim KJ, Kim MJ, Kim SH, Lee HJ, Ko JH, Lee YC, Suzuki A, Kim CH.
    Glycobiology; 2009 Mar 15; 19(3):229-39. PubMed ID: 18974200
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retina.
    Lüke M, Januschowski K, Lüke J, Peters S, Wirtz N, Yörük E, Lüke C, Bartz-Schmidt KU, Grisanti S, Szurman P.
    Br J Ophthalmol; 2009 Oct 15; 93(10):1396-400. PubMed ID: 19628500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.